AdaptHealth Corp. (NasdaqCM: AHCO)
Health Care · Health Care Providers & Services · US
$6.14
+1.24% today · -32.4% 1Y
AdaptHealth Corp. (NasdaqCM: AHCO) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $808.46M and employs 10,900 people.
Over the last twelve months the share price has lost 32.4%, trading between 5.21 and 13.43.
Tweenvest scores AdaptHealth Corp. across four factors: quality 53/100, value 78/100, growth 69/100. Its strongest factor is value.
AHCO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $808.46M
- Revenue (TTM)
- $3.36B
- P/E
- —
- EPS
- -1.68
- Dividend yield
- —
- Beta (5Y)
- 1.42
- 52-week high
- $13.43
- 52-week low
- $5.21
- Avg volume (3M)
- —
- Shares outstanding
- 133.41M
- Employees
- 10,900
- Next earnings
- —
About AdaptHealth Corp.
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
- ISIN
- US00653Q1022
- Founded
- 2012
- Listed since
- May 31, 2018
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| HPGC Renmintongtai Pharmaceutical CorporationSHSE: 600829 | $824.19M | CN¥9.52 | +0.95% |
| Thyrocare Technologies LimitedBSE: 539871 | $820.66M | Rs499.00 | -6.62% |
| Cowealth Medical China Co.,Ltd.SHSE: 603122 | $817.73M | CN¥13.76 | -0.72% |
| NEUCA S.A.WSE: NEU | $816.16M | zł703.00 | -0.57% |
| Jinxin Fertility Group LimitedSEHK: 1951 | $763.54M | HK$2.29 | +6.51% |
| Entero Healthcare Solutions LimitedNSEI: ENTERO | $753.80M | Rs1,676.20 | -0.27% |
| Hygeia Healthcare Holdings Co., LimitedSEHK: 6078 | $743.20M | HK$9.61 | +1.26% |
| WELL Health Technologies Corp.TSX: WELL | $742.64M | CA$4.14 | -3.94% |
Figures last refreshed Oct 11, 2026.